Navigation Links
Fourth Annual James E. Marshall OCD Foundation Beyond Beauty Dinner to Honor E. Scott Beattie, Chairman and CEO, Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO, Conde Nast Publications
Date:2/11/2008

Awareness...

Discovery...

Cure... CNN's Soledad O'Brien to Emcee and 'Torch Singer' Andrea Marcovicci to

Perform

NEW YORK, Feb. 11 /PRNewswire/ -- On Tuesday, February 12, 2008, The James E. Marshall OCD Foundation, which benefits genetic research and awareness for Obsessive-Compulsive Disorder, will honor E. Scott Beattie, Chairman and Chief Executive Officer of Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO of Conde Nast Publications, at the fourth annual Beyond Beauty dinner. The event to be held at the Union League in New York City, will feature Soledad O'Brien, anchor and special correspondent for CNN, as master of ceremonies, and will include a special performance by singer Andrea Marcovicci.

Founded in 2003 by the family of its namesake, The James E. Marshall OCD Foundation funds genetic research and aims to increase awareness of Obsessive Compulsive Disorder, a disease that affects one in four children and countless adults worldwide. Frequently misunderstood and financially under-funded, the costs of OCD exceed those of heart disease, cancer and diabetes combined. Funds raised by the Beyond Beauty dinner will go to Johns Hopkins School of Medicine and will be allocated by Dr. Gerald Nestadt, head of the Department of Psychiatry and Behavioral Science.

"Unless touched by this horrible disease firsthand, most people do not understand how truly devastating OCD can be -- not just for the sufferers, but for family, friends, and co-workers, who see how destructive the behavior can be," says Linda Marshall, President of Elysee Scientific Cosmetics. "Our biggest ally in changing public perceptions is the media, which can help shed light on this disease and stimulate discussion so we can erase the stigma associated with mental disorders. This is our mission: Awareness, Discovery, Cure."

E. Scott Beattie is Chairman and Chief Executive Officer of Elizabeth Arden Inc., a global prestige beauty products company. Since the inception of the business in 1992, Mr. Beattie has been involved in every element of Elizabeth Arden's expansion and development. During the fiscal year ending June 2007, net sales were over $1.1 billion. Elizabeth Arden products are sold in over 90 countries worldwide. Mr. Beattie has dedicated himself to building an organization that is entrepreneurial in spirit, utilizes a team- based approach, focusing on the needs of both its consumers and its retail partners and counts and treats its employees as its most valued resource.

Charles H. Townsend is President and Chief Executive Officer of Conde Nast Publications, home to many of the world's most celebrated magazines and websites, including Vogue, Allure, Vanity Fair, Glamour, GQ, style.com, Wired, epicurious.com, Conde Nast Portfolio, and The New Yorker. Since becoming CEO of the company in January 2004, Mr. Townsend has overseen the consolidation of Advance Magazine Group's diverse publishing assets under the Conde Nast Publications banner. Today, Conde Nast publishes twenty-six consumer magazines and their websites, eight commercial websites, and three business- to-business trade publications.

While the beauty industry is committed to helping people look beautiful on the outside, this event highlights how the industry helps them feel beautiful within as well, thus the name "Beyond Beauty."

For more information on The James E. Marshall Foundation please visit: http://www.elyseecosmetics.com/pages/foundation.php


'/>"/>
SOURCE The James E. Marshall OCD Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results
2. NightHawk Radiology Holdings, Inc. Announces Time Change for Fourth Quarter and Full-Year 2007 Earnings Conference Call
3. Huntsman to Discuss Fourth Quarter and Full Year 2007 Results on Friday, February 22, 2008
4. Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008
5. NHP Announces Fourth Quarter Earnings Release Date and Conference Call/Webcast
6. CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007
7. HCA Reports Fourth Quarter - Year End 2007 Results
8. DRAXIS Health Reports Fourth Quarter and Year End Results
9. drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007
10. PPD Reports Fourth Quarter and Year-End 2007 Financial Results
11. Emageon Inc. to Host Fourth Quarter 2007 Financial Results Conference Call February 21, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: